Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II

SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …

[HTML][HTML] Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources

SY Pan, G Litscher, SH Gao, SF Zhou, ZL Yu… - Evidence-based …, 2014 - hindawi.com
In recent years, increasing numbers of people have been choosing herbal medicines or
products to improve their health conditions, either alone or in combination with others. Herbs …

[HTML][HTML] New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics

SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang… - Evidence-based …, 2013 - hindawi.com
With tens of thousands of plant species on earth, we are endowed with an enormous wealth
of medicinal remedies from Mother Nature. Natural products and their derivatives represent …

Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4

SF Zhou - Current drug metabolism, 2008 - ingentaconnect.com
Human cytochrome P450 (CYP) 3A4 is the most abundant hepatic and intestinal phase I
enzyme that metabolizes approximately 50% marketed drugs. The crystal structure of bound …

Molecular mechanisms for tumour resistance to chemotherapy

ST Pan, ZL Li, ZX He, JX Qiu… - Clinical and Experimental …, 2016 - Wiley Online Library
Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

SF Zhou, CC Xue, XQ Yu, C Li… - Therapeutic drug …, 2007 - journals.lww.com
Abstract Cytochrome P450 (CYP) 3A4 is the most abundant enzyme of CYPs in the liver and
gut that metabolizes approximately 50% currently available drugs. A number of important …

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development

SF Zhou, LL Wang, YM Di, CC Xue… - Current medicinal …, 2008 - ingentaconnect.com
Human contains 49 ATP-binding cassette (ABC) transporter genes and the multidrug
resistance associated proteins (MRP1/ABCC1, MRP2/ABCC2, MRP3/ABCC3 …

Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2

SF Zhou, LP Yang, ZW Zhou, YH Liu, E Chan - The AAPS journal, 2009 - Springer
Human CYP1A2 is one of the major CYPs in human liver and metabolizes a variety of
clinically important drugs (eg, clozapine, tacrine, tizanidine, and theophylline), a number of …

Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2

SF Zhou, B Wang, LP Yang, JP Liu - Drug metabolism reviews, 2010 - Taylor & Francis
Human CYP1A2 is one of the major CYPs in human liver and metabolizes a number of
clinical drugs (eg, clozapine, tacrine, tizanidine, and theophylline; n> 110), a number of …